Smith & Nephew plc (LON:SN)
1,151.00
+37.00 (3.32%)
Jul 15, 2026, 4:48 PM GMT
Smith & Nephew Employees
Smith & Nephew had 16,988 employees as of December 31, 2025. The number of employees decreased by 361 or -2.08% compared to the previous year.
Employees
16,988
Change (1Y)
-361
Growth (1Y)
-2.08%
Revenue / Employee
269.59K GBP
Profits / Employee
27.34K GBP
Market Cap
9.69B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 16,988 | -361 | -2.08% |
| Dec 31, 2024 | 17,349 | -1,103 | -5.98% |
| Dec 31, 2023 | 18,452 | -560 | -2.95% |
| Dec 31, 2022 | 19,012 | 643 | 3.50% |
| Dec 31, 2021 | 18,369 | 455 | 2.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 96,100 |
| GSK plc | 66,841 |
| Haleon | 24,535 |
| Spire Healthcare Group | 17,800 |
| Convatec Group | 10,910 |
| Hikma Pharmaceuticals | 9,400 |
| CVS Group | 9,000 |
| Genus | 3,190 |
Smith & Nephew News
- 5 days ago - Smith & Nephew price target lowered to 1,550 GBp from 1,600 GBp at Citi - TheFly
- 7 days ago - New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications - GlobeNewsWire
- 7 days ago - New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions - GlobeNewsWire
- 15 days ago - Smith & Nephew PLC (SNN) Stock Down 4.8% -- Now Undervalued? GF Score: 84/100 - GuruFocus
- 22 days ago - Smith & Nephew price target lowered to 1,333 GBp at Morgan Stanley - TheFly
- 5 weeks ago - Is It Too Late to Buy Smith & Nephew PLC (SNN) After 3.2% Rally? GF Value Says Undervalued - GuruFocus
- 5 weeks ago - Smith & Nephew Transcript: Investor update - Transcripts
- 5 weeks ago - Smith & Nephew Slides: Investor update - Filings